Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00857948 · ClinicalTrials.gov registry record · Phase 2
Dose Ranging Study of Ivermectin Treatment Conditioner in Subjects With Head Lice Infestation
A Phase 2 study, sponsored by Topaz Pharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
- 78
- Enrollment target
NCT00857948 is a Phase 2 study that has completed, run by Topaz Pharmaceuticals. The registered enrollment target is 78 participants.
The verdict
NCT00857948, a Phase 2 study, has completed, sponsored by Topaz Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 78 participants
- Enrollment target
Study Summary
This is a Phase 2 single center study designed to compare the safety, local tolerability, and efficacy of 3 strengths of ivermectin treatment conditioner to placebo.
Interventions
- DRUG Placebo, vehicle control
- DRUG ivermectin treatment conditioner
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2009-03 |
| Est. Completion | 2009-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00857948
The ClinicalTrials.gov registry entry for NCT00857948 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 78 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Topaz Pharmaceuticals, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo, vehicle control is the first listed.
NCT00857948 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00857948 about?
NCT00857948 is a clinical study titled "Dose Ranging Study of Ivermectin Treatment Conditioner in Subjects With Head Lice Infestation". This is a Phase 2 single center study designed to compare the safety, local tolerability, and efficacy of 3 strengths of ivermectin treatment conditioner to placebo.
What is the current status of trial NCT00857948?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 78 participants. The study started on 2009-03. Estimated completion is 2009-04.
What interventions are being tested in trial NCT00857948?
The interventions under investigation include: Placebo, vehicle control (DRUG), ivermectin treatment conditioner (DRUG).
Who is sponsoring clinical trial NCT00857948?
This trial is sponsored by Topaz Pharmaceuticals, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.